What is ADMA Biologics's shares, issued?

ADMA Biologics (ADMA) reported shares, issued of $866.3K in Q4 2025.

ADMA Biologics ADMA Shares, Issued

Shares, Issued at other companies

The Travelers CompaniesTRV

212.6M-6.2%

CBIZCBZ

0-100%

Apollo Global ManagementAPO

576.5M+1.1%

U.S. BancorpUSB

2.1B0.0%

BlackstoneBX

751.5M+1.8%

Arthur J. GallagherAJG

256.9M—

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:SharesIssued.

The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's shares, issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's shares, issued?: ADMA Biologics (ADMA) reported shares, issued of $866.3K in Q4 2025.